<DOC>
	<DOCNO>NCT02502201</DOCNO>
	<brief_summary>The purpose research study determine effect environment six-minute walk test performance individual chronic obstructive pulmonary disease due alpha-1 antitrypsin deficiency . The aim study determine environmental impact physical performance population determine factor influence quality life . This study develop evaluate efficacy use indoor six-minute walk test determine eligibility ambulatory oxygen therapy .</brief_summary>
	<brief_title>Environment Effect Six-Minute Walk Test Performance</brief_title>
	<detailed_description>Participants ask come Clinical Research Center ( CRC ) visit last one hour . Participants ask review sign informed consent document participate trial . If participant agree participate sign consent , follow procedure do . If pulmonary function test perform past 18 month , standard spirometry test perform . Participants perform two six-minute walk test , one indoors one outdoors . First , randomly assign perform either indoor outdoor test first . Then participants vital sign take , perform first six-minute walk study immediately vital sign take . Participants rest period two six-minute walk test least 30 minute . Participants perform second six-minute walk test procedure first test .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<criteria>1 . Age 18 year . 2 . Have diagnosis congenital Alpha1 Antitrypsin Deficiency allelic combination ZZ . 3 . Have Forced Expiratory Volume 1 second ( FEV1 ) &lt; 50 % predict FEV1/forced vital capacity ( FVC ) &lt; 70 % ( Global Initiative Chronic Obstructive Lung Disease [ GOLD ] stage II , III , IV ) . 4 . Not currently prescribe Oxygen replacement rate great 2 liter . 5 . Willing able perform two sixminute walk test . 6 . Willing able provide write informed consent . 1 . Subject moderate severe pulmonary exacerbation 4 week study visit . 2 . History lung transplant . 3 . Severe concomitant disease ( e.g. , congestive heart failure , clinically significant pulmonary fibrosis , malignant disease [ exception skin cancer melanoma ] , history acute hypersensitivity pneumonitis reaction , current chronic hypersensitivity pneumonitis ) . 4 . Unwilling unable perform sixminute walk test . 5 . Mentally challenge adult subject give independent informed consent . 6 . In opinion investigator subject may compliance problem protocol procedure protocol . 7 . American Thoracic Society list absolute contraindication sixminute walk test : unstable angina myocardial infarction previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>six-minute walk</keyword>
</DOC>